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Estimates of the prevalence of urinary symptoms among men vary widely. In general health surveys of men over the age of 65, between 16 and 40% report having either urinary symptoms or a previous prostatectomy, or both (Spain 16%; USA 25%; Israel 40%).'-`A household survey undertaken in Michigan in 1983-84 found that 35% of men over the age of 60 had one or more symptoms of prostatism. 4 A review of general practice case notes in the UK suggested that 6% of men over the age of 60 had undisclosed 'marked prostatism', based on the presence of four urinary symptoms, and a further 14% had 'mild prostatism', with three symptoms. 5 In a questionnaire administered to men over the age of 60 who attended a health screening clinic in the UK, 18% reported five or more urinary symptoms.6 A recent study, defining benign prostatic hyperplasia using a combination of urinary symptoms, flow rates, and prostatic size, reported a prevalence among Scottish men aged 40 to 79 of 253 per 1000.7
A virtually identical study in the USA found that prostatism rose from 26% in the 40-49 age group to 46% in 70+ age group, higher than the prevalence found in the Scottish study. 8 These studies are not sufficient to assess the 'felt need'. They provide little information on the severity of symptoms and do not measure the extent to which men are bothered by their symptoms. The latter point is important as it has been suggested that a third of men with mild symptoms may not want treatment.9 This paper describes a survey of felt need for treatment of benign prostatic hyperplasia in the UK that addresses these issues. A subsequent paper will report on the relationship between the prevalence of urinary symptoms and demand for treatment.
Benign prostatic hyperplasia is the commonest cause of urinary symptoms affecting middle aged and elderly men. It is becoming an increasing challenge to the health service because of an aging population and the introduction of new forms of treatment. Knowledge of the prevalence of urinary symptoms and their impact on men form the basis of the three measures required by those involved in the planning and provision of services for benign prostatic hyperplasia: the number of men in the population experiencing urinary symptoms that bother them ( A symptom index, ranging from 0 to 30, was calculated by summing the scores of six urinary symptoms (fullness, frequency, intermittency, urgency, poor flow, and hesitancy) where each symptom was assigned one of the following values: never = 0, hardly ever = 1, less than half the time = 2, about half the time = 3, more than half the time = 4, and almost always = 5. Unlike the AUA-7 symptom index, nocturia was not included in our symptom index for three reasons: (a) it has many causes other than urinary tract disorders, such as cardiovascular disease and the person's fluid intake before going to bed, and is the symptom that responds least well to prostatectomy;'3 (b) in a validation study of the AUA index, the highest intersymptom correlation was between nocturia and frequency, and frequency was already included in the index; and (c) the categories of nocturia severity we obtained were too crude to use. The symptom index was categorised into four levels of severity; none (0), very mild (1), mild (2-9), moderate (10) (11) (12) (13) (14) (15) (16) (17) (18) , and severe (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) tionnaires) after a postal reminder. The age structure of those responding was similar to that of all men living in North West Thames region, except for those in the 55 to 59 age group, who seemed to be under-represented in our sample (table 1) . Responders were more likely to be white than would be expected from the male population in this age group. The comparison ofsubsamples ofresponders and non-responders (table 2) found no difference in mean age. Apparent non-responders included 8% who had either died or moved or for whom the general practitioner had no evidence of a medical record. In addition, for 2% of responders and 11 % of non-responders, although there was evidence that a record existed, these records could not be located. Comparison ofthe medical records available showed that responders were more likely to have undergone previous prostate surgery (7% v 1 %; p<005), but there was no significant difference in their medical histories of urinary symptoms. 
Results

CHARACTERISTICS OF THE SAMPLE
Of the 2000 men who were sent a questionnaire, 21 
Discussion
This study has described the prevalence and severity of urinary symptoms in British men aged 55 and over. Although most men report no urinary symptoms, 20% reported moderate or severe symptoms. Of these, only 28% found their symptoms a medium or big problem. Thirty seven per cent experienced interference with their daily activities at least some of the time, and 43% would be unhappy at the prospect of a future with their symptoms continuing at their current level.
Before any conclusions may be drawn, the limitations of this survey should be considered. Men in the 55 to 59 year age group were under-represented compared with the general population, although comparison of For example, we defined moderate or severe symptoms as a symptom index of greater than 9, giving a prevalence in the male population aged 55 and over of 204 per 1000. Reduction of the threshold to 8 would result in a prevalence of 227 per 1000; a threshold of 11 would result in a prevalence of 170 per 1000. Our survey measured the felt need for treatment rather than the normative need. The clinical decision to offer treatment is based on a combination of urinary symptoms and the results of urological investigation. Assessment of normative need is complicated by the absence of an accepted definition of benign prostate hyperplasia. Currently, there is a debate in the urological literature about the importance of each. Several studies have shown a poor correlation between symptoms and objective urological measures such as flow rates and residual volume.'5-'8 Given that most surgery is carried out to improve a man's quality of life, we therefore believe that the presence of urinary symptoms is an essential, though not the only, factor that should be measured when assigning the need for surgery in the population.
It has been suggested that there is a large proportion of men in the British population with undiagnosed but symptomatic prostatism.7 Our study supports this view. The only other study on the prevalence of urinary symptoms in men in the UK has been reported by Garraway et al. They reported a prevalence in men aged 40-79 years of 104 per 1000. '9 These figures refer to men with a symptom score of at least 11 out of a possible 48 points (eight symptoms each with a maximum score of six). If we were to use an equivalent cut-off point with our data, 7 out of 30, we would produce a prevalence of 292 per 1000. However, some important methodological differences between the two studies remain. In the study by Garraway et al, the men were younger (over 50% were under 55 years), 9% of men in the study population were excluded, and the response rate was lower (only 64%'9 compared with 78%). All of these might explain why they obtained a lower estimate of prevalence than we did. These factors could therefore reconcile our results with theirs.
The finding that 6 
